IntelliCyt recently announced the commercial launch of its iQue Screener.

According to the Albuquerque, NM-based company, the iQue is a high-throughput, high-content, integrated analyzer designed for screening cells and beads in suspension.

Using the system, researchers can obtain information on a cell-by-cell basis in 96- and 384-well microplates, IntelliCyt said. The system is capable of processing application-specific MultiCyt reagent kits, and the resulting data can be analyzed using IntelliCyt's ForeCyt software.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.